SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-18-007789
Filing Date
2018-01-10
Accepted
2018-01-10 06:11:04
Documents
11
Period of Report
2018-01-09
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A d519931d8ka.htm 8-K/A 15035
2 EX-10.2 d519931dex102.htm EX-10.2 945549
3 GRAPHIC g51993126aa.jpg GRAPHIC 211652
4 GRAPHIC g519931aasss_page1.jpg GRAPHIC 15708
5 GRAPHIC g519931app1.jpg GRAPHIC 55347
6 GRAPHIC g519931app2.jpg GRAPHIC 30074
7 GRAPHIC g519931g33o33.jpg GRAPHIC 27972
8 GRAPHIC g519931st18a.jpg GRAPHIC 652
9 GRAPHIC g519931st18bb.jpg GRAPHIC 25194
10 GRAPHIC g519931st19.jpg GRAPHIC 11546
11 GRAPHIC g519931st20.jpg GRAPHIC 10533
  Complete submission text file 0001193125-18-007789.txt   1489666
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35405 | Film No.: 18520284
SIC: 2834 Pharmaceutical Preparations